Human monoclonal antibodies for therapy of Pseudomonas infections
Reference17 articles.
1. Bjornson AB, Michael JG (1972) Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II: opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies. Infection and Immunity 5:775–782
2. Cross AS, Sadoff JC, Iglewski BH, Sokol PA (1980) Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans. J Infect Dis 142:538–546
3. Holder A, Wheeler R, Montie TC (1982) Flagellar preparations from Pseudomonas aeruginosa: animal protection studies. Infect Immunity 35:276–280
4. Kuriyama M, Ichimori Y, Iwasa S, Trukamoto K (1990) A human-human hybridoma secreting anti-Pseudomonas aeruginosa Exotoxin A monoclonal antibody with highly potent neutralizing activity. Cytotechnology 3:31–37
5. Lang AB, Fürer E, Larrick JW, Cryz SJ (1989) Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4 and 6 lipopolysaccharides. Infection and Immunity, 3851–3855